Timeline of aging research: Difference between revisions

From Wikipedia, the free encyclopedia
Content deleted Content added
Small improvement of just added sentenses
ce, →‎See also: added wikilinks for related content not included in this timeline, added 1 item from 2019 in science,2020 in science,2021 in science (see these pages' histories for attribution), added 1 2004 item
Line 1: Line 1:
{{Use dmy dates|date=May 2021}}
{{Use dmy dates|date=May 2021}}
{{short description|Timeline of notable events in the history of senescence research}}
{{short description|Timeline of notable events in the history of senescence research}}
People have always been interested in how to make their lives longer and healthier in old age. Already the most anсient Egyptian, Indian and Chinese books contain reasoning about aging. Ancient Egyptians used garlic in large quantities to extend their lifespan. [[Hippocrates]] ({{c.|460|370 BC}}) in his ''[[Aphorisms]]'' and [[Aristotle]] ([[384 BC|384]]&nbsp;–&nbsp;[[322 BC|322]]&nbsp;BC) in ''[[On Youth, Old Age, Life and Death, and Respiration|On youth and old age]]'' expresses their opinions about reasons for old age and gave advice about lifestyle. Medieval [[Persia]]n physician [[Ibn Sina]] ({{c.|lk=no|980}}&nbsp;–&nbsp;1037), known in the West as Avicenna, summarized achievements of the earlier generations about this issue. Descriptions of rejuvenation and immortality remedies are often found in the writings of alchemists. But all those remedies did not allow even alchemists themselves to live longer than a hundred years.<ref name="stambler2019">{{cite journal|author=Ilia Stambler |date=January 2019 |title=History of Life-Extensionism |url=https://books.google.com/books?id=yiLLDwAAQBAJ&q=History+of+Life-Extensionism+Ilia+Stambler+encyclopedia+of+biomedical+gerontology&pg=RA1-PA228 |journal=Encyclopedia of Biomedical Gerontology |pages=228–237 |doi=10.1016/B978-0-12-801238-3.11331-5 |isbn=9780128012383 |access-date=5 May 2021}}</ref><ref name="medi">{{cite web|author=В.Е. Чернилевский, В.Н. Крутько |url=https://medi.ru/info/10323/ |title=История изучения средств продления жизни |language=ru |trans-title=History of studying the means of extending life |publisher=National Gerontology Center (of Russia) |date=2000 |access-date=5 May 2021}}</ref><ref name="grignolio">{{cite book| vauthors = Grignolio A, Franceschi C |title=eLS |date=15 June 2012 |chapter=History of Research into Ageing/Senescence |publisher=American Cancer Society |chapter-url=https://onlinelibrary.wiley.com/doi/abs/10.1002/9780470015902.a0023955 |doi=10.1002/9780470015902.a0023955|isbn=978-0470016176 }}</ref>
This timeline lists notable events in the history of research of [[senescence]] or biological aging. People have always been interested in how to make their lives longer and healthier in old age. Already the most anсient Egyptian, Indian and Chinese books contain reasoning about [[aging]]. Ancient Egyptians used [[garlic]] in large quantities to extend [[Self-care|their]] [[lifespan]]. [[Hippocrates]] ({{c.|460|370 BC}}) in his ''[[Aphorisms]]'' and [[Aristotle]] ([[384 BC|384]]&nbsp;–&nbsp;[[322 BC|322]]&nbsp;BC) in ''[[On Youth, Old Age, Life and Death, and Respiration|On youth and old age]]'' expresses their opinions about reasons for old age and gave advice about lifestyle. Medieval [[Persia]]n physician [[Ibn Sina]] ({{c.|lk=no|980}}&nbsp;–&nbsp;1037), known in the West as Avicenna, summarized achievements of the earlier generations about this issue.<ref name="stambler2019"/><ref name="medi"/><ref name="grignolio"/>
== Background ==
Descriptions of rejuvenation and immortality remedies are often found in the writings of alchemists. But all those remedies did not allow even alchemists themselves to live longer than a hundred years.<ref name="stambler2019">{{cite journal|author=Ilia Stambler |date=January 2019 |title=History of Life-Extensionism |url=https://books.google.com/books?id=yiLLDwAAQBAJ&q=History+of+Life-Extensionism+Ilia+Stambler+encyclopedia+of+biomedical+gerontology&pg=RA1-PA228 |journal=Encyclopedia of Biomedical Gerontology |pages=228–237 |doi=10.1016/B978-0-12-801238-3.11331-5 |isbn=9780128012383 |access-date=5 May 2021}}</ref><ref name="medi">{{cite web|author=В.Е. Чернилевский, В.Н. Крутько |url=https://medi.ru/info/10323/ |title=История изучения средств продления жизни |language=ru |trans-title=History of studying the means of extending life |publisher=National Gerontology Center (of Russia) |date=2000 |access-date=5 May 2021}}</ref><ref name="grignolio">{{cite book| vauthors = Grignolio A, Franceschi C |title=eLS |date=15 June 2012 |chapter=History of Research into Ageing/Senescence |publisher=American Cancer Society |chapter-url=https://onlinelibrary.wiley.com/doi/abs/10.1002/9780470015902.a0023955 |doi=10.1002/9780470015902.a0023955|isbn=978-0470016176 }}</ref>


Though the [[Life expectancy|average lifespan]] of people through the past millennia increased significantly,<ref name="Kyriazis">{{cite journal | vauthors = Kyriazis M | title = Ageing Throughout History: The Evolution of Human Lifespan | journal = Journal of Molecular Evolution | volume = 88 | issue = 1 | pages = 57–65 | date = January 2020 | pmid = 31197416 | pmc = | doi = 10.1007/s00239-019-09896-2 | bibcode = 2020JMolE..88...57K | s2cid = 189763393 }}</ref> maximum lifespan almost did not change - even in ancient times there were fairly well and unbiasedly documented cases when some people lived for more than a hundred years (for example, [[Terentia]] who lived 103 or 104 years). While among the billions of people of the modern world, there is only one case of life over 120 years ([[Jeanne Calment]], 122 years). The super-long lives of people that are mentioned in ancient books, apparently, are highly exaggerated, since archaeological data show that even the oldest of the ancient people lived no more than modern [[supercentenarian]]s.<ref name="medi" /> In some cases the exaggeration, possibly, is not intentional but occurs due to errors in translation between languages and [[Chronology#Synchronism|synchronization]] of chronological systems. The species limit of human life is estimated by scientists at 125–127 years,<ref name="JGA">{{cite journal | vauthors = Andersen SL, Sebastiani P, Dworkis DA, Feldman L, Perls TT | title = Health span approximates life span among many supercentenarians: compression of morbidity at the approximate limit of life span | journal = [[The Journals of Gerontology#Series A|The Journals of Gerontology: Series A]] | volume = 67 | issue = 4 | pages = 395–405 | date = April 2012 | pmid = 22219514 | pmc = 3309876 | doi = 10.1093/gerona/glr223 }}</ref><ref>{{cite journal | vauthors = Weon BM, Je JH | title = Theoretical estimation of maximum human lifespan | journal = Biogerontology | volume = 10 | issue = 1 | pages = 65–71 | date = February 2009 | pmid = 18560989 | doi = 10.1007/s10522-008-9156-4 | s2cid = 8554128 }}</ref> and even in the most ideal conditions a person will not live longer due to aging of the body.
Though the [[Life expectancy|average lifespan]] of people through the past millennia increased significantly,<ref name="Kyriazis">{{cite journal | vauthors = Kyriazis M | title = Ageing Throughout History: The Evolution of Human Lifespan | journal = Journal of Molecular Evolution | volume = 88 | issue = 1 | pages = 57–65 | date = January 2020 | pmid = 31197416 | pmc = | doi = 10.1007/s00239-019-09896-2 | bibcode = 2020JMolE..88...57K | s2cid = 189763393 }}</ref> maximum lifespan almost did not change - even in ancient times there were fairly well and unbiasedly documented cases when some people lived for more than a hundred years (for example, [[Terentia]] who lived 103 or 104 years). While among the billions of people of the modern world, there is only one case of life over 120 years ([[Jeanne Calment]], 122 years). The super-long lives of people that are mentioned in ancient books, apparently, are highly exaggerated, since archaeological data show that even the oldest of the ancient people lived no more than modern [[supercentenarian]]s.<ref name="medi" /> In some cases the exaggeration, possibly, is not intentional but occurs due to errors in translation between languages and [[Chronology#Synchronism|synchronization]] of chronological systems. The species limit of human life is estimated by scientists at 125–127 years,<ref name="JGA">{{cite journal | vauthors = Andersen SL, Sebastiani P, Dworkis DA, Feldman L, Perls TT | title = Health span approximates life span among many supercentenarians: compression of morbidity at the approximate limit of life span | journal = [[The Journals of Gerontology#Series A|The Journals of Gerontology: Series A]] | volume = 67 | issue = 4 | pages = 395–405 | date = April 2012 | pmid = 22219514 | pmc = 3309876 | doi = 10.1093/gerona/glr223 }}</ref><ref>{{cite journal | vauthors = Weon BM, Je JH | title = Theoretical estimation of maximum human lifespan | journal = Biogerontology | volume = 10 | issue = 1 | pages = 65–71 | date = February 2009 | pmid = 18560989 | doi = 10.1007/s10522-008-9156-4 | s2cid = 8554128 }}</ref> and even in the most ideal conditions a person will not live longer due to aging of the body.
Line 121: Line 124:


* '''2004''' As a result of the use of anti-aging therapy, a team of scientists led by Stephen Spindler managed to extend the life of a group of already adult mice to an average of 3.5 years. For this achievement, the first Methuselah Mouse Rejuvenation 'M Prize' was awarded.<ref>{{Cite news|author=Bill Christensen|url=https://www.livescience.com/3725-methuselah-mouse-rejuvenation-prize-awarded.html|title=First Methuselah Mouse Rejuvenation 'M Prize' Awarded|work=[[Live Science]]|date=1 December 2004}}</ref>
* '''2004''' As a result of the use of anti-aging therapy, a team of scientists led by Stephen Spindler managed to extend the life of a group of already adult mice to an average of 3.5 years. For this achievement, the first Methuselah Mouse Rejuvenation 'M Prize' was awarded.<ref>{{Cite news|author=Bill Christensen|url=https://www.livescience.com/3725-methuselah-mouse-rejuvenation-prize-awarded.html|title=First Methuselah Mouse Rejuvenation 'M Prize' Awarded|work=[[Live Science]]|date=1 December 2004}}</ref>

* '''2004''' Creation of the first curated [[biological database|database]] of genes related to human ageing: [[GenAge]].<ref>{{cite journal |last1=Magalhães |first1=João Pedro de |last2=Toussaint |first2=Olivier |title=GenAge: a genomic and proteomic network map of human ageing |journal=FEBS Letters |date=2004 |volume=571 |issue=1-3 |pages=243–247 |doi=10.1016/j.febslet.2004.07.006 |url=https://febs.onlinelibrary.wiley.com/doi/full/10.1016/j.febslet.2004.07.006 |access-date=26 June 2021 |language=en |issn=1873-3468}}</ref>


* '''2006''' Creation of [[induced stem cells]] (iSC) from somatic cells by the simultaneous action of several factors. First produced by the Japanese scientist [[Shinya Yamanaka]].<ref>{{cite journal | vauthors = Takahashi K, Yamanaka S | title = Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors | journal = Cell | volume = 126 | issue = 4 | pages = 663–76 | date = August 2006 | pmid = 16904174 | doi = 10.1016/j.cell.2006.07.024 | hdl-access = free | author-link2 = Shinya Yamanaka | hdl = 2433/159777 | s2cid = 1565219 }}</ref><ref>{{cite journal | vauthors = Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, Yamanaka S | title = Induction of pluripotent stem cells from adult human fibroblasts by defined factors | journal = Cell | volume = 131 | issue = 5 | pages = 861–72 | date = November 2007 | pmid = 18035408 | doi = 10.1016/j.cell.2007.11.019 | hdl-access = free | author-link7 = Shinya Yamanaka | hdl = 2433/49782 | s2cid = 8531539 }}</ref><ref>{{cite journal | vauthors = Okita K, Ichisaka T, Yamanaka S | title = Generation of germline-competent induced pluripotent stem cells | journal = Nature | volume = 448 | issue = 7151 | pages = 313–7 | date = July 2007 | pmid = 17554338 | doi = 10.1038/nature05934 | bibcode = 2007Natur.448..313O | s2cid = 459050 | author-link3 = Shinya Yamanaka }}</ref> In '''2012''', Shinya Yamanaka and [[John Gurdon]] received the [[Nobel Prize in Physiology or Medicine|Nobel Prize]] for their work on reprogramming mature cells into pluripotent cells.<ref>{{cite web|url=https://www.nobelprize.org/prizes/medicine/2012/summary/ |title=The Nobel Prize in Physiology or Medicine 2012 |work=NobelPrize.org}}</ref>
* '''2006''' Creation of [[induced stem cells]] (iSC) from somatic cells by the simultaneous action of several factors. First produced by the Japanese scientist [[Shinya Yamanaka]].<ref>{{cite journal | vauthors = Takahashi K, Yamanaka S | title = Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors | journal = Cell | volume = 126 | issue = 4 | pages = 663–76 | date = August 2006 | pmid = 16904174 | doi = 10.1016/j.cell.2006.07.024 | hdl-access = free | author-link2 = Shinya Yamanaka | hdl = 2433/159777 | s2cid = 1565219 }}</ref><ref>{{cite journal | vauthors = Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, Yamanaka S | title = Induction of pluripotent stem cells from adult human fibroblasts by defined factors | journal = Cell | volume = 131 | issue = 5 | pages = 861–72 | date = November 2007 | pmid = 18035408 | doi = 10.1016/j.cell.2007.11.019 | hdl-access = free | author-link7 = Shinya Yamanaka | hdl = 2433/49782 | s2cid = 8531539 }}</ref><ref>{{cite journal | vauthors = Okita K, Ichisaka T, Yamanaka S | title = Generation of germline-competent induced pluripotent stem cells | journal = Nature | volume = 448 | issue = 7151 | pages = 313–7 | date = July 2007 | pmid = 17554338 | doi = 10.1038/nature05934 | bibcode = 2007Natur.448..313O | s2cid = 459050 | author-link3 = Shinya Yamanaka }}</ref> In '''2012''', Shinya Yamanaka and [[John Gurdon]] received the [[Nobel Prize in Physiology or Medicine|Nobel Prize]] for their work on reprogramming mature cells into pluripotent cells.<ref>{{cite web|url=https://www.nobelprize.org/prizes/medicine/2012/summary/ |title=The Nobel Prize in Physiology or Medicine 2012 |work=NobelPrize.org}}</ref>
Line 167: Line 172:
* '''2018''' The [[World Health Organization]] included in the international classification of diseases [[ICD-11]] a special additional code XT9T, signaling the relationship of a disease with age. Due to this, after the final approval of the ICD-11 in May 2019, aging began to be officially recognized as a fundamental factor that increases the risk of diseases, the severity of their course and the difficulty of treatment.<ref>{{cite journal |date=1 August 2018 |url=https://www.thelancet.com/journals/landia/article/PIIS2213-8587(18)30214-6/fulltext |title=Opening the door to treating ageing as a disease |journal=[[The Lancet]] Diabetes & Endocrinology |volume=6 |issue=8 |pages=587 |doi=10.1016/S2213-8587(18)30214-6 |pmid=30053981}}</ref><ref>{{cite web|author=Biogerontology Research Foundation |url=https://www.eurekalert.org/pub_releases/2018-07/brf-who070218.php |title=World Health Organization adds extension code for 'aging-related' via ICD-11 |work=[[American Association for the Advancement of Science#EurekAlert!|EurekAlert]] |date=2 July 2018}}</ref><ref>{{cite web|author=Steve Hill |url=https://www.lifespan.io/news/a-step-closer-to-aging-being-classified-as-a-disease/ |title=Getting Aging Classified as a Disease – Daria Khaltourina |work=[[Life Extension Advocacy Foundation|Lifespan.io]] |date=31 August 2018}}</ref><ref>{{cite web|url=https://www.fightaging.org/archives/2018/09/inching-towards-the-regulatory-classification-of-aging-as-a-disease/ |title=Inching Towards the Regulatory Classification of Aging as a Disease |website=Fight Aging! |date=3 September 2018}}</ref><ref>{{cite web|author=Oksana Andreiuk |url=https://medium.com/@oandreiuk/lets-talk-about-the-world-health-organisation-recognising-ageing-as-a-disease-risk-factor-4ca8ac89e59b |title=Let’s talk about the World Health Organisation recognising ageing as a disease risk factor, updating the ICD for the first time in 35 years. |website=[[Medium (website)|Medium]] |date=12 September 2018}}</ref>
* '''2018''' The [[World Health Organization]] included in the international classification of diseases [[ICD-11]] a special additional code XT9T, signaling the relationship of a disease with age. Due to this, after the final approval of the ICD-11 in May 2019, aging began to be officially recognized as a fundamental factor that increases the risk of diseases, the severity of their course and the difficulty of treatment.<ref>{{cite journal |date=1 August 2018 |url=https://www.thelancet.com/journals/landia/article/PIIS2213-8587(18)30214-6/fulltext |title=Opening the door to treating ageing as a disease |journal=[[The Lancet]] Diabetes & Endocrinology |volume=6 |issue=8 |pages=587 |doi=10.1016/S2213-8587(18)30214-6 |pmid=30053981}}</ref><ref>{{cite web|author=Biogerontology Research Foundation |url=https://www.eurekalert.org/pub_releases/2018-07/brf-who070218.php |title=World Health Organization adds extension code for 'aging-related' via ICD-11 |work=[[American Association for the Advancement of Science#EurekAlert!|EurekAlert]] |date=2 July 2018}}</ref><ref>{{cite web|author=Steve Hill |url=https://www.lifespan.io/news/a-step-closer-to-aging-being-classified-as-a-disease/ |title=Getting Aging Classified as a Disease – Daria Khaltourina |work=[[Life Extension Advocacy Foundation|Lifespan.io]] |date=31 August 2018}}</ref><ref>{{cite web|url=https://www.fightaging.org/archives/2018/09/inching-towards-the-regulatory-classification-of-aging-as-a-disease/ |title=Inching Towards the Regulatory Classification of Aging as a Disease |website=Fight Aging! |date=3 September 2018}}</ref><ref>{{cite web|author=Oksana Andreiuk |url=https://medium.com/@oandreiuk/lets-talk-about-the-world-health-organisation-recognising-ageing-as-a-disease-risk-factor-4ca8ac89e59b |title=Let’s talk about the World Health Organisation recognising ageing as a disease risk factor, updating the ICD for the first time in 35 years. |website=[[Medium (website)|Medium]] |date=12 September 2018}}</ref>


==== 2019 ====
* '''2019''' Increasing the lifespan of ''[[Caenorhabditis elegans]]'' (free-living [[nematode]]s) by 5–6 times (by 400–500%) using simultaneous impact in [[Insulin signal transduction pathway|IIS]] and [[mTOR|TOR]] pathways. This is equivalent to how a human would live 400–500 years.<ref>{{cite web|url=https://mdibl.org/press-release/mdi-biological-scientists-identify-pathways-that-extend-lifespan-by-500-percent/ |title=MDI Biological Scientists Identify Pathways That Extend Lifespan by 500 Percent |work=[[MDI Biological Laboratory]] |date=8 January 2020}}</ref><ref>{{cite web|author=Michael Irving |url=https://newatlas.com/biology/worm-lifespans-extended-500-percent/ |title=Worm lifespans extended 500 percent in surprising new aging study |work=New Atlas |date=8 January 2020}}</ref><ref>{{cite web|author=Kristin Houser |url=https://futurism.com/scientists-extend-lifespan-worms-500-percent |title=Scientists Extend Lifespan of Worms by 500 Percent |work=Futurism.com|date=9 January 2020}}</ref><ref>{{cite web|author=Stephen Johnson |url=https://bigthink.com/surprising-science/aging-research |title=Biologists extend worm lifespan by 500% in surprising discovery on aging |work=[[Big Think]] |date=13 January 2020}}</ref>
* The lifespan of ''[[Caenorhabditis elegans]]'' (free-living [[nematode]]s) was increased by 5–6 times (by 400–500%) using simultaneous impact in [[Insulin signal transduction pathway|IIS]] and [[mTOR|TOR]] pathways. This is equivalent to how a human would live 400–500 years.<ref>{{cite web|url=https://mdibl.org/press-release/mdi-biological-scientists-identify-pathways-that-extend-lifespan-by-500-percent/ |title=MDI Biological Scientists Identify Pathways That Extend Lifespan by 500 Percent |work=[[MDI Biological Laboratory]] |date=8 January 2020}}</ref><ref>{{cite web|author=Michael Irving |url=https://newatlas.com/biology/worm-lifespans-extended-500-percent/ |title=Worm lifespans extended 500 percent in surprising new aging study |work=New Atlas |date=8 January 2020}}</ref><ref>{{cite web|author=Kristin Houser |url=https://futurism.com/scientists-extend-lifespan-worms-500-percent |title=Scientists Extend Lifespan of Worms by 500 Percent |work=Futurism.com|date=9 January 2020}}</ref><ref>{{cite web|author=Stephen Johnson |url=https://bigthink.com/surprising-science/aging-research |title=Biologists extend worm lifespan by 500% in surprising discovery on aging |work=[[Big Think]] |date=13 January 2020}}</ref>

* Scientists at the [[Mayo Clinic]] report the first successful use of [[senolytics]], a new class of drug with potential anti-aging benefits, to remove [[Cellular senescence|senescent cells]] from human patients with a kidney disease.<ref>{{cite web|url=https://newsnetwork.mayoclinic.org/discussion/mayo-researchers-demonstrate-senescent-cell-burden-is-reduced-in-humans-by-senolytic-drugs/|title=Mayo researchers demonstrate senescent cell burden is reduced in humans by senolytic drugs|work=Mayo Clinic|date=18 September 2019|access-date=20 September 2019|publisher=Mayo Clinic}}</ref><ref>{{cite web|url=https://www.ebiomedicine.com/article/S2352-3964(19)30591-2/pdf|title=Senolytics decrease senescent cells in humans: Preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney disease|work=EBioMedicine|date=20 September 2019|access-date=20 September 2019|publisher=EBioMedicine}}</ref>

* By [[combination therapy|combining]] doses of [[lithium]], [[trametinib]] and [[rapamycin]] into a single treatment, researchers extend the lifespan of [[Drosophila melanogaster|fruit flies]] (''Drosophila'') by 48%.<ref>{{cite web|url=https://www.ucl.ac.uk/news/2019/sep/fruit-flies-live-longer-combination-drug-treatment|title=Fruit flies live longer with combination drug treatment|date=30 September 2019|access-date=2 October 2019|publisher=University College London}}</ref><ref>{{cite journal |last1=Castillo-Quan |first1=Jorge Iván |last2=Tain |first2=Luke S. |last3=Kinghorn |first3=Kerri J. |last4=Li |first4=Li |last5=Grönke |first5=Sebastian |last6=Hinze |first6=Yvonne |last7=Blackwell |first7=T. Keith |last8=Bjedov |first8=Ivana |last9=Partridge |first9=Linda |title=A triple drug combination targeting components of the nutrient-sensing network maximizes longevity |journal=Proceedings of the National Academy of Sciences |date=2019-10-15 |volume=116 |issue=42 |pages=20817–20819 |url=https://www.pnas.org/content/early/2019/09/26/1913212116 |access-date=26 June 2021}}</ref>

* Researchers at Harvard Medical School identify a link between neural activity and human longevity. Neural excitation is linked to shorter life, while suppression of overactivity appears to extend lifespan.<ref>{{cite web|url=https://www.sciencedaily.com/releases/2019/10/191016131224.htm|title=In a first, scientists pinpoint neural activity's role in human longevity|date=16 October 2019|access-date=28 October 2019|publisher=Science Daily}}</ref><ref>{{cite journal |last1=Zullo |first1=Joseph M. |last2=Drake |first2=Derek |last3=Aron |first3=Liviu |last4=O’Hern |first4=Patrick |last5=Dhamne |first5=Sameer C. |last6=Davidsohn |first6=Noah |last7=Mao |first7=Chai-An |last8=Klein |first8=William H. |last9=Rotenberg |first9=Alexander |last10=Bennett |first10=David A. |last11=Church |first11=George M. |last12=Colaiácovo |first12=Monica P. |last13=Yankner |first13=Bruce A. |title=Regulation of lifespan by neural excitation and REST |journal=Nature |date=October 2019 |volume=574 |issue=7778 |pages=359–364 |doi=10.1038/s41586-019-1647-8 |url=https://www.nature.com/articles/s41586-019-1647-8 |access-date=26 June 2021 |language=en |issn=1476-4687}}</ref>

* Scientists in Japan use [[Single-cell analysis|single-cell RNA analysis]] to find that [[supercentenarians]] have an excess of [[Cytotoxic T cell|cytotoxic CD4 T-cells]], a type of immune cell.<ref>{{cite web|url=https://www.sciencedaily.com/releases/2019/11/191113101845.htm|title=Could cytotoxic T-cells be a key to longevity?|date=13 November 2019|access-date=19 November 2019|publisher=Science Daily}}</ref><ref>{{cite journal |last1=Hashimoto |first1=Kosuke |last2=Kouno |first2=Tsukasa |last3=Ikawa |first3=Tomokatsu |last4=Hayatsu |first4=Norihito |last5=Miyajima |first5=Yurina |last6=Yabukami |first6=Haruka |last7=Terooatea |first7=Tommy |last8=Sasaki |first8=Takashi |last9=Suzuki |first9=Takahiro |last10=Valentine |first10=Matthew |last11=Pascarella |first11=Giovanni |last12=Okazaki |first12=Yasushi |last13=Suzuki |first13=Harukazu |last14=Shin |first14=Jay W. |last15=Minoda |first15=Aki |last16=Taniuchi |first16=Ichiro |last17=Okano |first17=Hideyuki |last18=Arai |first18=Yasumichi |last19=Hirose |first19=Nobuyoshi |last20=Carninci |first20=Piero |title=Single-cell transcriptomics reveals expansion of cytotoxic CD4 T cells in supercentenarians |journal=Proceedings of the National Academy of Sciences |date=2019-11-26 |volume=116 |issue=48 |pages=24242–24251 |url=https://www.pnas.org/content/116/48/24242 |access-date=26 June 2021}}</ref>

==== 2020 ====
* Scientists report, using public [[List of biological databases|biological data]] on 1.75 m people with known lifespans overall, to have identified 10 [[Locus (genetics)|genomic loci]] which appear to [[genetics of aging|intrinsically influence]] [[healthspan]], [[Life expectancy|lifespan]], and [[longevity]] – of which half have not been reported previously at [[Genome-wide association study|genome-wide significance]] and most being associated with [[cardiovascular disease]] – as well as haem metabolism as a promising candidate for further research within the field.<ref name="ironmeta">{{cite news |title=Blood iron levels could be key to slowing ageing, gene study shows |url=https://phys.org/news/2020-07-blood-iron-key-ageing-gene.html |access-date=18 August 2020 |work=phys.org |language=en}}</ref><ref>{{cite journal |last1=Timmers |first1=Paul R. H. J. |last2=Wilson |first2=James F. |last3=Joshi |first3=Peter K. |last4=Deelen |first4=Joris |title=Multivariate genomic scan implicates novel loci and haem metabolism in human ageing |journal=Nature Communications |date=16 July 2020 |volume=11 |issue=1 |page=3570 |doi=10.1038/s41467-020-17312-3 |pmid=32678081 |pmc=7366647 |bibcode=2020NatCo..11.3570T |language=en |issn=2041-1723}}</ref>

* Scientists report that after mice exercise their livers secrete the protein [[GPLD1]], which is also elevated in elderly humans who exercise regularly, that this is associated with improved cognitive function in aged mice and that increasing the amount of GPLD1 produced by the mouse liver in old mice could yield many [[Neurobiological effects of physical exercise|benefits of regular exercise for their brains]] – such as increased BDNF-levels, neurogenesis, and improved cognitive functioning in tests.<ref>{{cite news |title=Brain benefits of exercise can be gained with a single protein |url=https://medicalxpress.com/news/2020-07-brain-benefits-gained-protein.html |accessdate=18 August 2020 |work=medicalxpress.com |language=en}}</ref><ref>{{cite journal |last1=Horowitz |first1=Alana M. |last2=Fan |first2=Xuelai |last3=Bieri |first3=Gregor |last4=Smith |first4=Lucas K. |last5=Sanchez-Diaz |first5=Cesar I. |last6=Schroer |first6=Adam B. |last7=Gontier |first7=Geraldine |last8=Casaletto |first8=Kaitlin B. |last9=Kramer |first9=Joel H. |last10=Williams |first10=Katherine E. |last11=Villeda |first11=Saul A. |title=Blood factors transfer beneficial effects of exercise on neurogenesis and cognition to the aged brain |journal=Science |date=10 July 2020 |volume=369 |issue=6500 |pages=167–173 |doi=10.1126/science.aaw2622 |url=https://science.sciencemag.org/content/369/6500/167 |accessdate=18 August 2020 |language=en |issn=0036-8075}}</ref><!--Should this be removed or a tag/category be added?-->

* Scientists report that yeast cells of the same genetic material and within the same environment age in two distinct ways, describe a biomolecular mechanism that can determine which process dominates during aging and [[genetically engineer]] a novel [[aging]] route with substantially [[life extension|extended lifespan]].<ref>{{cite news |title=Researchers discover 2 paths of aging and new insights on promoting healthspan |url=https://phys.org/news/2020-07-paths-aging-insights-healthspan.html |access-date=17 August 2020 |work=phys.org |language=en}}</ref><ref>{{cite journal |title=A programmable fate decision landscape underlies single-cell aging in yeast |journal=Science |doi=10.1126/science.aax9552 |bibcode=2020Sci...369..325L |last1=Li |first1=Yang |last2=Jiang |first2=Yanfei |last3=Paxman |first3=Julie |last4=O'Laughlin |first4=Richard |last5=Klepin |first5=Stephen |last6=Zhu |first6=Yuelian |last7=Pillus |first7=Lorraine |last8=Tsimring |first8=Lev S. |last9=Hasty |first9=Jeff |last10=Hao |first10=Nan |year=2020 |volume=369 |issue=6501 |pages=325–329 |pmid=32675375 |pmc=7437498 }}</ref><!--Should this be removed or a tag/category be added?-->

==== 2021 ====
<!-- There are 4 items on the talk page about which there could be discussion about whether and how to include them here; some more items on the talk page could be added to earlier years -->
* Researchers report that [[myeloid cell]]s are drivers of a [[Maladaptation|maladaptive]] [[brain inflammation|inflammation]] element of [[Aging brain|brain-ageing]] in mice and that this can be [[rejuvenation|reversed]] or prevented via inhibition of their [[Prostaglandin EP2 receptor#Nervous system|EP2 signalling]].<ref>{{cite news |title=Study reveals immune driver of brain aging |url=https://medicalxpress.com/news/2021-01-reveals-immune-driver-brain-aging.html |access-date=13 February 2021 |work=medicalxpress.com |language=en}}</ref><ref>{{cite journal |last1=Minhas |first1=Paras S. |last2=Latif-Hernandez |first2=Amira |last3=McReynolds |first3=Melanie R. |last4=Durairaj |first4=Aarooran S. |last5=Wang |first5=Qian |last6=Rubin |first6=Amanda |last7=Joshi |first7=Amit U. |last8=He |first8=Joy Q. |last9=Gauba |first9=Esha |last10=Liu |first10=Ling |last11=Wang |first11=Congcong |last12=Linde |first12=Miles |last13=Sugiura |first13=Yuki |last14=Moon |first14=Peter K. |last15=Majeti |first15=Ravi |last16=Suematsu |first16=Makoto |last17=Mochly-Rosen |first17=Daria |last18=Weissman |first18=Irving L. |last19=Longo |first19=Frank M. |last20=Rabinowitz |first20=Joshua D. |last21=Andreasson |first21=Katrin I. |title=Restoring metabolism of myeloid cells reverses cognitive decline in ageing |journal=Nature |date=February 2021 |volume=590 |issue=7844 |pages=122–128 |doi=10.1038/s41586-020-03160-0 |pmid=33473210 |bibcode=2021Natur.590..122M |url=https://www.nature.com/articles/s41586-020-03160-0 |access-date=13 February 2021 |language=en |issn=1476-4687}}</ref>


== See also ==
== See also ==
{{Science year nav|{{CURRENTYEAR}}}}<!--Timeline of biotechnology-->
* [[Longevity escape velocity]]
* [[Longevity escape velocity]]
* [[Life extension]]
* [[Life extension]]
* [[Rejuvenation]]
* [[Rejuvenation]]
* [[Biogerontology]]
* [[Biogerontology]]
=== Excluded fields of research ===
Notable events in these fields of research that relate to life extension and healthspan are not included in this timeline
* [[Nutritional science#History]] –
* [[Health#Maintaining]] – conventional ways of maintaining health for life extension
** [[Exercise#Health effects]]
** [[Neurobiological effects of physical exercise]]


== References ==
== References ==
Line 200: Line 232:
[[Category:Senescence]]
[[Category:Senescence]]
[[Category:Medicine timelines]]
[[Category:Medicine timelines]]
[[Category:Biology timelines]]
[[Category:Life extension]]

Revision as of 19:04, 26 June 2021

This timeline lists notable events in the history of research of senescence or biological aging. People have always been interested in how to make their lives longer and healthier in old age. Already the most anсient Egyptian, Indian and Chinese books contain reasoning about aging. Ancient Egyptians used garlic in large quantities to extend their lifespan. Hippocrates (c. 460 – c. 370 BC) in his Aphorisms and Aristotle (384 – 322 BC) in On youth and old age expresses their opinions about reasons for old age and gave advice about lifestyle. Medieval Persian physician Ibn Sina (c. 980 – 1037), known in the West as Avicenna, summarized achievements of the earlier generations about this issue.[1][2][3]

Background

Descriptions of rejuvenation and immortality remedies are often found in the writings of alchemists. But all those remedies did not allow even alchemists themselves to live longer than a hundred years.[1][2][3]

Though the average lifespan of people through the past millennia increased significantly,[4] maximum lifespan almost did not change - even in ancient times there were fairly well and unbiasedly documented cases when some people lived for more than a hundred years (for example, Terentia who lived 103 or 104 years). While among the billions of people of the modern world, there is only one case of life over 120 years (Jeanne Calment, 122 years). The super-long lives of people that are mentioned in ancient books, apparently, are highly exaggerated, since archaeological data show that even the oldest of the ancient people lived no more than modern supercentenarians.[2] In some cases the exaggeration, possibly, is not intentional but occurs due to errors in translation between languages and synchronization of chronological systems. The species limit of human life is estimated by scientists at 125–127 years,[5][6] and even in the most ideal conditions a person will not live longer due to aging of the body.

Some scientists believe that, even if medicine learns how to treat all major diseases, that will increase the average lifespan of people in developed countries by only about 10 years.[2] For example, biogerontologist Leonard Hayflick stated that the natural average lifespan for humans is 92 years.[7] Meanwhile the life expecancy for Japanese already now is more than 84 years,[8] and for Monaco it is reported to be more than 89 years.[9] It may not be possible to achieve further increases without development of new biomedical technologies and approaches. Searches of various equivalents of the elixir of youth happened yet in ancient times: people hoped to find a miraculous remedy in faraway territories, tried to use magic and alchemy. Scientific and technological attempts began at the end of the 19th century. For their intended purpose, all of them turned out to be inefficient at best, sometimes led to premature death, but they had many useful and sometimes unexpected consequences.

Timeline

Search for an elixir of youth in ancient times

  • 15687 BC — years of life of the Chinese emperor Wu of Han, who persistently tried to find a way to achieve immortality, mainly by means of magic. He used services of various magicians. But Wu of Han was not a naive person – he thoroughly rechecked their abilities and if he saw that the person is a quack, he executed him.
  • 63 BC–14 AD — years of life of Caesar Augustus, the first Roman emperor, who is considered one of the most effective leaders of the Ancient Rome. For him an eternal youth was an obsession. In particular, contrary to the Roman tradition to create statues as realistic as possible, he always ordered to portray himself young. There are many of his "youthful" statues but researchers still don't know how he looked in old age.
  • 3rd17th century — the period of alchemy. There are several directions in alchemy, and it was distributed over a huge territory. But almost everywhere, in one form or another, there was the concept of a "philosopher's stone" – some substance that is able to turn other metals into gold, and when taken internally in small doses, heal all diseases, rejuvenate an old body and even give biological immortality. Alternatively, there were attempts to prepare "pills of immortality". During centuries alchemy gradually transformed to chemistry, in parallel giving birth to many adjacent sciences or enriching them. It is worth noticing the direction of iatrochemistry – a rational direction of alchemy with the main goal of preparing medicinal products. The pioneers of iatrochemistry were Paracelsus (1493–1541), Jan Baptist van Helmont (1580–1644) and Franciscus Sylvius (1614–1672). The converging field of alchemy was transformed into pharmacy.
  • 1513 — searching for the Fountain of Youth was one of the purposes of the expedition of the Spanish conquistador Juan Ponce de León, in the result of which Florida was discovered.
  • 1550 — a Venetian nobleman Luigi Cornaro published the book "The Art of Living Long", describing the style of life for the achievement of longevity.[10] The book was translated into many languages. The English version of the book till the 19th century went through more than 50 editions. The main idea of the book: in order to live many years, you need to live in moderation, eat simply and little. In his youth Cornaro led a free and immoderate life, as a result by the age of 35 he had many problems with health. But changing his lifestyle he was able to live till 98 years (1467–1566).[11] (Though it is possible that he increase his age by about 17 years to give his recommendations more weight.)

Scientific experiments from the end of the 19th century to WWII (the first steps)

From the end of the 19th century, systematic scientific and technical studies began on the processes of slowing down aging and possible rejuvenation. The period of world history between the two world wars is a very complicated, difficult and ambiguous time of world history. In many spheres of life, there were ideas that were radical-bold, but not always intelligent, ethical and moral from the point of view of modern knowledge, foundations and norms. This also affected the aging research, the spirit of which corresponded to the spirit of that time: attempting bold experiments, often on people, intensively implementing in practice treatments that we may now consider ridiculous. Those attempts had both bad and good consequences. But those researches were already scientific. As it often happens in science, it is often difficult to establish priority considering, who was the first person beginning to use one or another approach. Usually the first experiments are done by enthusiasts and have doubtful positive effects. Some researchers work in parallel. Then at some moment the persons emerge who developed the approaches and made them public.

  • 1825 The first publication of the Gompertz–Makeham law of mortality that in the simplest form is: p = a + bx. According to the law, the probability of death p is defined as the sum of age-independent component a and the component depending of age bx which with age increases exponentially. If we place organisms in an absolutely protected environment and in this way make the first component negligible, the probability of death will be completely defined by the second component which actually describes the probability to die from aging.
  • 1889 Rejuvenation experiment conducted on himself by the French doctor Charles-Édouard Brown-Séquard. He made himself a few subcutaneous injections from the testicles of young dogs and guinea pigs and claimed that the injections were accompanied by significant and long pain, but then he observed an improvement of the physical condition of the organism and increase of mental activity. Experiments of other scientists, at first, produced the same results but later it became clear that the period of reinforced activity is followed by a period of decline. At the moment of the experiment Charles-Édouard Brown-Séquard was 72 years old. After the experiment he claimed he felt as if he became younger by 30 years. However, 5 years later he died. But other doctors picked up this method and it created the foundation for the development of hormone replacement therapy.[2][14][15][11]
  • 1903 Ilya Mechnikov coined the term "gerontology".[16][17][3] The term originates from the Greek γέρων, geron, "old man" and -λογία, -logia, "study of". From 1897 to 1916 Mechnikov conducted many studies on the effect of acidified dairy products (especially Bulgarian yogurt and bacteria used for its production) on longevity and quality of life in old age. He developed the concept of probiotic diet that promotes long healthy life.[14][15] In 1908 Mechnikov received the Nobel Prize for his work on immunology (adjacent area of his research).[18] Adhering to his diet, Mechnikov lived a very long life compared to his short-lived relatives.[19]
  • 1914 Dr. Frank Lydston from Chicago performed human testis transplants on several patients, including himself, and said that there were some rejuvenating consequences (such as returning his gray hair to its original color and improving of sexual performance).[11] These works remained little known. The work of Leo L. Stanley, that he began to do since 1919, received much more prominence (see further).
  • 1915–1917 Experiments to find out the effects of food restriction on the life duration of rats, conducted by Thomas Osborne. Apparently, these were the first systematic experiments in this direction.[2][20] These experiments remained little known. The method was popularized by Clive McCay in 1934–1935 (see further).
  • 1910s–1930s Austrian physiologist Eugen Steinach was trying to achieve rejuvenation effects by means of different surgical operations such as partial vasectomy for men, ligation of fallopian tubes for women, transplantation of testicles, etc. And although later these operations were found to be ineffective, they allowed the researchers to recognize the role of the sexual glands and sexual hormones in the formation of the first and secondary gender characteristics, enriched physiology, laid the foundation for the science of sexology, formed the basis for sex reassignment surgeries. From 1921 to 1938, Eugen Steinach was nominated for the Nobel Prize many times (according to various sources, from 6 to 11 times), but never received it.[14][15][21][22][23]
  • 1920s–1930s In medical practice, sex gland transplants were introduced to obtain rejuvenating effects. (Though separate experiments in this direction were done even earlier, even in antiquity.) The earlier mentioned operations of Dr. Frank Lydston in 1914 remained almost unnoticed. But the works of Leo Leonidas Stanley quickly received widespread scientific notice. Stanley was a physician at a prison in California and began to do these operations since 1919, using glands of executed criminals.[11] In the following years, such operations were done by dozens of physicians (including Eugen Steinach) but they became most famous due to the activity of the French surgeon of Russian extraction Serge/Samuel Voronoff. It was believed that transplantation of sex glands provides more durable effects than injection of a suspension of ground glands. In case of transplantation from human to human, the glands of executed criminals were usually used. But due to a shortage of materials, the sex glands of young healthy monkeys were widely used, which were specially grown for this purpose (usually thin sections of the glands were implanted). In some cases soon after the operation, there were indeed noticeable positive changes in appearance and behavior (with a rapid senility of the body soon following). There were many messages about wonderful results of the operations that, apparently, were false advertising of unscrupulous doctors. But numerous failures became apparent, for which the method was sharply criticized and banned.[2] Serge Voronoff and some other doctors, who claimed producing wonderful results after the operations, got bad reputation. However, despite the failure in the main direction, the conducted research led to the emergence of allotransplantation and xenotransplantation directions in surgery, brought significant knowledge about the effect of sex hormones on the body, stimulated their study.[14][15] It may be just a coincidence but in 1929–33 several varieties of estrogen were discovered, and testosterone was isolated in 1935. Also these experiments formed the basis for several works of public culture (for example, Heart of a Dog by Mikhail Bulgakov, The Adventure of the Creeping Man from the series about Sherlock Holmes, a song Monkey-Doodle-Doo of Irving Berlin).
  • 1926–1928 Experiments on rejuvenation by blood transfusion, conducted by Alexander Bogdanov in the world's first Institute for Blood Transfusion espicially created for that purpose. Bogdanov himself died during one of the experiments, because at that time little was known about the factors of blood compatibility of different people.[2][15] The institute, having undergone several renames, exists and is still actively working. The second head of the institute was Alexander Bogomolets (see further).
  • 1930s Beginning of attempts of rejuvenation by methods of cell injections. A special role belongs here to the Swiss physician Paul Niehans – he was not the first but he was the one who developed this approach the most. Among his patients there were many famous people (including Winston Churchill, Charles de Gaulle, Pope Pius XII).[2][14] So, in 1952, about 3000 injections of about 10 cm3 of cell suspension were reported. As a consequence, cell therapy and regenerative medicine were formed. Since the 1960s, attempts have been made to inject not only whole cells but also their constituent parts (such as isolated DNA and RNA).[14][15] But usage of embryonic drugs sometimes caused serious complications, so the American association of physicians recognized the method of cell therapy as dangerous.[2]
  • 1930 The first world's journal about aging and longevity. It was established in Japan and has the name Acta Gerontologica Japonica (Yokufuen Chosa Kenkyu Kiyo).[25]
  • 1933 The first institute in the world dedicated to study of aging. It was created in Kishinev (at that time the Kingdom of Romania) by Dimu Kotsovsky. Initially the institute was maintained by his own means, and was subsequently recognized by the Romanian government. The name is Romanian: Institutul Pentru Studierea si Combaterea Batranetii = German: Institut für Altersforschung und Altersbekämpfung = Institute for The Study and Combat of Aging.[26]
  • 1934 The first widely known scientific publication on the impact of dietary restriction on life expectancy, authored by Clive McCay.[27][28][29] McCay's group carried out intensive research in this direction in 1930-43, soon other scientists began to do related research.[2] The effect of increasing life expectancy by starvation is usually observed in rats and mice, whose development until puberty is very labile (growth retardation and puberty, decreased metabolism and body temperature). In larger animals, such as rabbits, dogs and monkeys, the effect is less pronounced. The impact of fasting on human life expectancy still remains a question where not everything is clear and is unambiguous.[2]
  • 1936 The first European (and Western) journal about aging and longevity. It was published in Kishinev by Dimu Kotsovsky. During the first year of existence it was called Monatsberichte,[30] then got the name German: Altersprobleme: Zeitschrift für Internationale Altersforschung und Altersbekämpfung = "Problems of Aging: Journal for the International Study and Combat of Aging". The journal published materials mostly in the German language, less in French and English.[26]
  • 1937 A Ukrainian Soviet pathophysiologist Alexander Bogomolets created antireticular cytotoxic serum in the hope to extend life of people to 150 years. Although the drug did not achieve its main goal, it has become widely used for the treatment of a number of diseases, especially infectious diseases and fractures.[2][14][15] The serum of Bogomolets was actively used in Soviet hospitals during WWII. For his work, Alexander Bogomolets received in 1941 the Stalin Prize,[31] which for Soviet scientists of those years was even more important than the Nobel Prize.
  • 1938 The first specialized society dedicated to the study of aging. It was formed in Germany, Leipzig and was named the German Society for Aging Research (German: Deutsche Gesellschaft für Altersforschung, soon renamed to Deutsche Gesellschaft für Alternsforschung). The founder is Max Bürger [de]. He also established the specialized journal Zeitschrift für Altersforschung – it is already the third such journal in the world after the previously mentioned Japanese and Romanian journals.[32]
  • 1938 The world's first scientific conference on aging and longevity in 1938 in Kiev, that was convened by Alexander Bogomolets.[1][33]

After WWII until the end of the 20th century (accumulation of modern knowledge)

As the world was recovering from the complex dramatic events of the 1930s and the terrible WWII, it became more practical. Research tools and technologies of another level appeared. Thanks to these technologies, it became understandable what really occurs inside cells and between them (for example, the model of double helix of DNA was created in 1953). At the same time the changed ethical norms did not allow to conduct cardinal experiments on humans, as it was possible in previous decades, and the influence of different factors could be estimated only implicitly.

  • 1950 Largely thanks to the collaborative efforts of Korenchevsky and Cowdry, the International Association of Gerontology is formed, later renamed to the International Association of Gerontology and Geriatrics (IAGG). The organization was registered in Belgium, and that is where its first conference took place. Slowly, gradually, the ideas began to spread that the problems of aging cannot be solved within the framework and efforts of one nation – therefore the international interaction is necessary.[1]
  • 1954 Vladimir Dilman formulated the hypothesis of aging that at first become known only in the USSR, as the elevation hypothesis. In 1968 it took the form and became known as the neuroendocrine theory of aging.[35][36][37]
  • 1977 To explain aging, Thomas Kirkwood proposed the disposable soma theory. According to the theory, the organism has only a limited amount of resources that it has to allocate between different purposes (such as growth, reproduction, repair of damage). Aging occurs due to the limitation of resources that the body can afford to spend on repair.[4]
  • 1990 Formation of the Gerontology Research Group (GRG) which searches for supercentenarians around the world and verifies their age. Whenever possible, the organization tries to collect data on why these people live significantly longer than the average person. The organization regularly publishes a list of the oldest verified living supercentenarians.[54]
  • 1992 National Archive of Computerized Data on Aging (NACDA) published in the Internet the first 28 datasets related to aging. Gradually the number of published datasets has grown to over 1600 and continues to grow. These datasets are available to any researcher around the world at no charge, so they can search in them for new patterns. The site also provides some tools to facilitate analysis.[55]
  • 1997 The absolute record for the duration of human life. The French woman Jeanne Calment lived 122 years and 164 days (the record is still held).
  • 1998 A record for the duration of life among males. The American of Danish descent Christian Mortensen lived 115 years and 252 days.

21st century (transforming knowledge into technology)

The research activity has increased. There is a shift of focus of the scientific community form passive study of aging and building theories to attempts to interfere in the process to extend lives of organisms beyond their genetic limits. Scientific-commercial companies appear, which aim to create practical technologies for measuring the biological age of a person (in contrast to chronological age) and extend the life of people to a greater extend than the healthy lifestyle and preventive medicine can provide. In society and media there are discussions not only about whether a significant prolongation of life is physically possible, but also whether it is appropriate, about the possibility of granting aging an official status of a disease, and about the possibility of mass testing on human volunteers.

  • 2003 Andrzej Bartke created a mouse that lived 1819 days (5 years without 7 days), while the maximum lifespan for this species is 1030–1070 days.[2] By human standards, such longevity is equivalent to about 180 years.[59]
  • 2004 As a result of the use of anti-aging therapy, a team of scientists led by Stephen Spindler managed to extend the life of a group of already adult mice to an average of 3.5 years. For this achievement, the first Methuselah Mouse Rejuvenation 'M Prize' was awarded.[63]
  • 2007 Extension of mouse lifespan via deletion of insulin receptor in the brain.[27][69]
  • 2007 The book Ending Aging written by Aubrey de Grey and his research assistant Michael Rae.
  • 2008 (approximately) It was observed that different variants of FOXO3 gene are associated with human longevity. Since then, research has been conducted to better understand its functions and the mechanism of action.[71][72][73][74]
  • 2009 A second pharmacological agent (namely, rapamycin) was shown to be capable to increase the lifespan of mice. For this discovery Davе Sharp receive a special prize from the Methuselah Foundation.[27][76][77]
  • 2012 It was discovered that protein Sirtuin 6 (SIRT6) regulates the lifespan of male mice (but not female mice).[27][78]
  • 2013 The scientific journal Cell published the article "The Hallmarks of Aging", that was translated to several languages and determined the directions of many studies.[79]
  • 2013 A record for the duration of life among males. Japanese Jiroemon Kimura lived 115 years and 54 days (that is 167 days longer than the previous record).
  • 2013 It was discovered that brain-specific overexpression of Sirtuin 1 (SIRT1) is also capable to extend lifespan and delay aging in mice.[27][80]
  • 2013 Google and other investors created the company Calico to combat aging and related diseases. Investors provided Calico with more than a billion dollars of funding. Arthur Levinson became CEO of the company and one of its investors.[81][82][83][84]
  • 2010s second half The emergence of official discussions about the possibility of recognizing aging as a disease.[87][88][89][90][91]
  • 2016 It was found that the replenishment of NAD+ in the organism of mice through precursor molecules improves the functioning of mitochondria and stem cells, and also leads to an increase in their lifespan.[27][92] One of these NAD+ precursor molecules is NMN.[93][94] After this discovery, some companies began to sell NMN for a large price (as dietary supplement) positioning it as a means of slowing aging, although serious research indicating that NMN can prolong the life of humans is not known at the time of this writing. NMN benefits for humans continues to be a question of doubt.
  • 2016 Demonstration that a combination of longevity associated drugs can additively extend lifespan, at least in mice.[27][95]
  • 2016 As part of the implementation of the SENS programs, researchers managed to make two mitochondrial genes, ATP8 and ATP6, stably express from the cell nucleus in the cell culture.[96]
  • 2017 The discovery that a naturally occurring polymorphism in human signaling pathways is in some cases associated with health and longevity. It was also detected that, the same as in mice, this association can depend on the gender (it can be observed for one gender but not for another). This indicates that by correctly influencing these pathways, it is theoretically possible to alter lifespan and healthspan in humans.[27][97]
  • 2018 The World Health Organization included in the international classification of diseases ICD-11 a special additional code XT9T, signaling the relationship of a disease with age. Due to this, after the final approval of the ICD-11 in May 2019, aging began to be officially recognized as a fundamental factor that increases the risk of diseases, the severity of their course and the difficulty of treatment.[99][100][101][102][103]

2019

  • Researchers at Harvard Medical School identify a link between neural activity and human longevity. Neural excitation is linked to shorter life, while suppression of overactivity appears to extend lifespan.[112][113]

2020

  • Scientists report that after mice exercise their livers secrete the protein GPLD1, which is also elevated in elderly humans who exercise regularly, that this is associated with improved cognitive function in aged mice and that increasing the amount of GPLD1 produced by the mouse liver in old mice could yield many benefits of regular exercise for their brains – such as increased BDNF-levels, neurogenesis, and improved cognitive functioning in tests.[118][119]
  • Scientists report that yeast cells of the same genetic material and within the same environment age in two distinct ways, describe a biomolecular mechanism that can determine which process dominates during aging and genetically engineer a novel aging route with substantially extended lifespan.[120][121]

2021

See also

Excluded fields of research

Notable events in these fields of research that relate to life extension and healthspan are not included in this timeline

References

  1. ^ a b c d e f Ilia Stambler (January 2019). "History of Life-Extensionism". Encyclopedia of Biomedical Gerontology: 228–237. doi:10.1016/B978-0-12-801238-3.11331-5. ISBN 9780128012383. Retrieved 5 May 2021.
  2. ^ a b c d e f g h i j k l m n В.Е. Чернилевский, В.Н. Крутько (2000). "История изучения средств продления жизни" [History of studying the means of extending life] (in Russian). National Gerontology Center (of Russia). Retrieved 5 May 2021.
  3. ^ a b c Grignolio A, Franceschi C (15 June 2012). "History of Research into Ageing/Senescence". eLS. American Cancer Society. doi:10.1002/9780470015902.a0023955. ISBN 978-0470016176.
  4. ^ a b c d Kyriazis M (January 2020). "Ageing Throughout History: The Evolution of Human Lifespan". Journal of Molecular Evolution. 88 (1): 57–65. Bibcode:2020JMolE..88...57K. doi:10.1007/s00239-019-09896-2. PMID 31197416. S2CID 189763393.
  5. ^ Andersen SL, Sebastiani P, Dworkis DA, Feldman L, Perls TT (April 2012). "Health span approximates life span among many supercentenarians: compression of morbidity at the approximate limit of life span". The Journals of Gerontology: Series A. 67 (4): 395–405. doi:10.1093/gerona/glr223. PMC 3309876. PMID 22219514.
  6. ^ Weon BM, Je JH (February 2009). "Theoretical estimation of maximum human lifespan". Biogerontology. 10 (1): 65–71. doi:10.1007/s10522-008-9156-4. PMID 18560989. S2CID 8554128.
  7. ^ Watts G (June 2011). "Leonard Hayflick and the limits of ageing". The Lancet. 377 (9783): 2075. doi:10.1016/S0140-6736(11)60908-2. PMID 21684371. S2CID 205963134.
  8. ^ "Life expectancy and Healthy life expectancy, data by country". World Health Organization. 4 December 2020. Retrieved 5 May 2021.
  9. ^ "Life expectancy at birth". CIA World Factbook. 5 May 2021.
  10. ^ Cornaro L (2016). The Art of Living Long. Forgotten Books. p. 214. ISBN 978-1-330-67886-2.
  11. ^ a b c d Haber C (June 2004). "Life extension and history: the continual search for the fountain of youth". The Journals of Gerontology: Series A. 59 (6): B515-22. doi:10.1093/gerona/59.6.B515. PMID 15215256.
  12. ^ a b Lipsky MS, King M (November 2015). "Biological theories of aging". Disease-a-Month. 61 (11): 460–6. doi:10.1016/j.disamonth.2015.09.005. PMID 26490576.
  13. ^ Jessica Kelly. "Wear-and-Tear Theory". Lumen Learning.
  14. ^ a b c d e f g h Stambler I (June 2014). "The unexpected outcomes of anti-aging, rejuvenation, and life extension studies: an origin of modern therapies". Rejuvenation Research. 17 (3): 297–305. doi:10.1089/rej.2013.1527. PMID 24524368.
  15. ^ a b c d e f g h Ilia Stambler (17 February 2021). "Have anti-aging interventions worked? Some lessons from the history of anti-aging experiments" (video). YouTube.
  16. ^ Harris DK (1988). Dictionary of Gerontology. New York: Greenwood Press. p. 80. ISBN 9780313252877.
  17. ^ Metchnikoff E (1903). The Nature of Man: Studies in Optimistic Philosophy. Translated by Mitchell PC. New York and London: G.P. Putnam's Sons. OCLC 173625.
  18. ^ "The Nobel Prize in Physiology or Medicine 1908". NobelPrize.org.
  19. ^ International Longevity Alliance (13 February 2021). "ILA Conference – Metchnikoff Day" (video). YouTube.
  20. ^ Osborne TB, Mendel LB, Ferry EL (March 1917). "The Effect of Retardation of Growth Upon the Breeding Period and Duration of Life of Rats". Science. 45 (1160): 294–5. Bibcode:1917Sci....45..294O. doi:10.1126/science.45.1160.294. PMID 17760202.
  21. ^ Södersten P, Crews D, Logan C, Soukup RW (March 2014). "Eugen Steinach: the first neuroendocrinologist". Endocrinology. 155 (3): 688–95. doi:10.1210/en.2013-1816. PMID 24302628.
  22. ^ Krischel M, Hansson N (May 2017). "Ageing: Rejuvenation study stirs old memories". Nature. 546 (7656): 33. Bibcode:2017Natur.546...33K. doi:10.1038/546033e. PMID 28569802. S2CID 52798966.
  23. ^ "Nomination Archive | Eugen Steinach". nobelprize.org. April 2020. Retrieved 26 April 2021.
  24. ^ "The Nobel Prize in Physiology or Medicine 1912". NobelPrize.org.
  25. ^ Stambler, Ilia (29 August 2014). "reference No. 438". A History of Life-Extensionism in the Twentieth Century. Longevity History. p. 540. ISBN 978-1500818579.
  26. ^ a b Stambler, Ilia (29 August 2014). "Allies – The Kingdom of Great Romania. Dimu Kotsovsky". A History of Life-Extensionism in the Twentieth Century. Longevity History. p. 540. ISBN 978-1500818579.
  27. ^ a b c d e f g h i j k l m Zainabadi K (April 2018). "A brief history of modern aging research". Experimental Gerontology. 104: 35–42. doi:10.1016/j.exger.2018.01.018. PMID 29355705. S2CID 3972313.
  28. ^ McCay CM, Crowell M (October 1934). "Prolonging the Life Span". The Scientific Monthly. 39 (5): 405–414. Bibcode:1934SciMo..39..405M. JSTOR 15813.
  29. ^ McCay CM, Crowell MF, Maynard LA (1 July 1935). "The Effect of Retarded Growth Upon the Length of Life Span and Upon the Ultimate Body Size" (PDF). The Journal of Nutrition. 10 (1): 63–79. doi:10.1093/jn/10.1.63.
  30. ^ A cover scan of the first issue of the journal Monatsberichte
  31. ^ "Alexander Alexandrovich Bogomolets: biography, scientific works, the basics of the theory". en.sodiummedia.com. Retrieved 5 May 2021.
  32. ^ Stambler, Ilia (29 August 2014). "Institutionalization of gerontology – Max Bürger". A History of Life-Extensionism in the Twentieth Century. Longevity History. p. 540. ISBN 978-1500818579.
  33. ^ Bogomolets AA, ed. (1939). Старость. (Труды конференции по проблеме генеза старости и профилактики преждевременного стрения организма) [Old age. (Proceedings of the conference on the problem of the genesis of old age and the prevention of premature abrasion of the body)] (in Russian). Kiev: UkrSSR Academy of Sciences Publishing House. p. 490.
  34. ^ Medawar P.B. (1952). Lewis (ed.). An Unresolved Problem in Biology. London.{{cite book}}: CS1 maint: location missing publisher (link)
  35. ^ Ward Dean (22 March 2012). "Neuroendocrine Theory of Aging". warddeanmd.com. Retrieved 5 May 2021.
  36. ^ Dilman VM (June 1971). "Age-associated elevation of hypothalamic, threshold to feedback control, and its role in development, ageine, and disease". The Lancet. 1 (7711): 1211–9. doi:10.1016/s0140-6736(71)91721-1. PMID 4103080.
  37. ^ Dilman VM, Revskoy SY, Golubev AG (1986). "Neuroendocrine-ontogenetic mechanism of aging: toward an integrated theory of aging". International Review of Neurobiology. 28: 89–156. doi:10.1016/S0074-7742(08)60107-5. ISBN 9780123668288. PMID 3542876.
  38. ^ Harman D (November 1981). "The aging process". Proceedings of the National Academy of Sciences of the United States of America. 78 (11): 7124–8. Bibcode:1981PNAS...78.7124H. doi:10.1073/pnas.78.11.7124. PMC 349208. PMID 6947277.
  39. ^ Gerschman R, Gilbert DL, Nye SW, Dwyer P, Fenn WO (May 1954). "Oxygen poisoning and x-irradiation: a mechanism in common". Science. 119 (3097): 623–6. Bibcode:1954Sci...119..623G. doi:10.1126/science.119.3097.623. PMID 13156638. S2CID 27600003.
  40. ^ Williams G.C. (1957). "Pleiotropy, natural selection, and the evolution of senescence". Evolution. 11 (4): 398–411. doi:10.2307/2406060. JSTOR 2406060.
  41. ^ Failla G (September 1958). "The aging process and cancerogenesis". Annals of the New York Academy of Sciences. 71 (6): 1124–40. Bibcode:1958NYASA..71.1124F. doi:10.1111/j.1749-6632.1958.tb46828.x. PMID 13583876.
  42. ^ Szilard L (January 1959). "On the Nature of the Aging Process". Proceedings of the National Academy of Sciences of the United States of America. 45 (1): 30–45. Bibcode:1959PNAS...45...30S. doi:10.1073/pnas.45.1.30. PMC 222509. PMID 16590351.
  43. ^ Boniewska-Bernacka E (2016). "Selected Theories of Aging" (PDF). Higher School's Pulse. 10: 36–39.
  44. ^ Greider CW, Blackburn EH (December 1985). "Identification of a specific telomere terminal transferase activity in Tetrahymena extracts". Cell. 43 (2 Pt 1): 405–13. doi:10.1016/0092-8674(85)90170-9. PMID 3907856. S2CID 17747801.
  45. ^ a b c Ido T, Tomita G, Kitazawa Y (March 1991). "Diurnal variation of intraocular pressure of normal-tension glaucoma. Influence of sleep and arousal". Ophthalmology. 98 (3): 296–300. doi:10.1038/onc.2010.15. PMID 2023748. S2CID 11726588.
  46. ^ Olovnikov AM (1971). "[Principle of marginotomy in template synthesis of polynucleotides]" [The principle of marginotomy in matrix synthesis of polynucleotides]. Doklady Akademii Nauk SSSR (in Russian). 201 (6): 1496–9. PMID 5158754.
  47. ^ Olovnikov AM (September 1973). "A theory of marginotomy. The incomplete copying of template margin in enzymic synthesis of polynucleotides and biological significance of the phenomenon". Journal of Theoretical Biology. 41 (1): 181–90. doi:10.1016/0022-5193(73)90198-7. PMID 4754905.
  48. ^ "The 2009 Nobel Prize in Physiology or Medicine – Illustrated Presentation". NobelPrize.org.
  49. ^ Yegorov, Yegor; Zelenin, A.V. (13 February 2011). "Racing for cell immortality, telomeres, telomerase, and the measure of health". Russian Journal of Developmental Biology. 42 (1): 53–56. doi:10.1134/S1062360411010061. PMID 21442903.
  50. ^ Gavrilov LA, Gavrilova NS (1986). Skulachev WP (ed.). Биология продолжительности жизни: Количественные аспекты [Biology of Life Span: Quantitative Aspects] (in Russian) (1st ed.). Moscow: Nauka. p. 167.
  51. ^ Gavrilov LA, Gavrilova NS (1991). Skulachev VP (ed.). Biology of Life Span: A Quantitative Approach (1st ed.). New York: Chur. p. 385. ISBN 978-3718649839.
  52. ^ Gavrilov LA, Gavrilova NS (December 2001). "The reliability theory of aging and longevity". Journal of Theoretical Biology. 213 (4): 527–45. doi:10.1006/jtbi.2001.2430. PMID 11742523.
  53. ^ A.J.S. Rayl (13 May 2002). "Aging, in Theory: A Personal Pursuit. Do body system redundancies hold the key?" (PDF). The Scientist. 16 (10): 20.
  54. ^ "GRG World Supercentenarian Rankings List". Gerontology Research Group.
  55. ^ "About Us". NACDA. Retrieved 7 May 2021.
  56. ^ Eccles M (20 August 2012). "Senescence Associated β-galactosidase Staining". Bio-protocol. 2 (16). doi:10.21769/BioProtoc.247.
  57. ^ Bodnar AG, Ouellette M, Frolkis M, Holt SE, Chiu CP, Morin GB, et al. (January 1998). "Extension of life-span by introduction of telomerase into normal human cells". Science. 279 (5349): 349–52. Bibcode:1998Sci...279..349B. doi:10.1126/science.279.5349.349. PMID 9454332.
  58. ^ Vellai T, Takacs-Vellai K, Zhang Y, Kovacs AL, Orosz L, Müller F (December 2003). "Genetics: influence of TOR kinase on lifespan in C. elegans". Nature. 426 (6967): 620. Bibcode:2003Natur.426..620V. doi:10.1038/426620a. PMID 14668850. S2CID 52833339.
  59. ^ Valerie Sprague (4 September 2003). "Battle for 'old mouse' prize". BBC News Online.
  60. ^ Apfeld J, O'Connor G, McDonagh T, DiStefano PS, Curtis R (December 2004). "The AMP-activated protein kinase AAK-2 links energy levels and insulin-like signals to lifespan in C. elegans". Genes & Development. 18 (24): 3004–9. doi:10.1101/gad.1255404. PMC 535911. PMID 15574588.
  61. ^ de Grey AD (15 June 2004). "The unfortunate influence of the weather on the rate of ageing: why human caloric restriction or its emulation may only extend life expectancy by 2–3 years". Gerontology. 51 (2): 73–82. doi:10.1371/journal.pbio.0020187. PMC 423155. PMID 15711074.{{cite journal}}: CS1 maint: unflagged free DOI (link)
  62. ^ Robert Anton Wilson (November 1978). "Next Stop, Immortality". Future Life (6).
  63. ^ Bill Christensen (1 December 2004). "First Methuselah Mouse Rejuvenation 'M Prize' Awarded". Live Science.
  64. ^ Magalhães, João Pedro de; Toussaint, Olivier (2004). "GenAge: a genomic and proteomic network map of human ageing". FEBS Letters. 571 (1–3): 243–247. doi:10.1016/j.febslet.2004.07.006. ISSN 1873-3468. Retrieved 26 June 2021.
  65. ^ Takahashi K, Yamanaka S (August 2006). "Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors". Cell. 126 (4): 663–76. doi:10.1016/j.cell.2006.07.024. hdl:2433/159777. PMID 16904174. S2CID 1565219.
  66. ^ Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, Yamanaka S (November 2007). "Induction of pluripotent stem cells from adult human fibroblasts by defined factors". Cell. 131 (5): 861–72. doi:10.1016/j.cell.2007.11.019. hdl:2433/49782. PMID 18035408. S2CID 8531539.
  67. ^ Okita K, Ichisaka T, Yamanaka S (July 2007). "Generation of germline-competent induced pluripotent stem cells". Nature. 448 (7151): 313–7. Bibcode:2007Natur.448..313O. doi:10.1038/nature05934. PMID 17554338. S2CID 459050.
  68. ^ "The Nobel Prize in Physiology or Medicine 2012". NobelPrize.org.
  69. ^ Taguchi A, Wartschow LM, White MF (July 2007). "Brain IRS2 signaling coordinates life span and nutrient homeostasis". Science. 317 (5836): 369–72. Bibcode:2007Sci...317..369T. doi:10.1126/science.1142179. PMID 17641201. S2CID 84884057.
  70. ^ Anisimov VN, Berstein LM, Egormin PA, Piskunova TS, Popovich IG, Zabezhinski MA, et al. (September 2008). "Metformin slows down aging and extends life span of female SHR mice". Cell Cycle. 7 (17): 2769–73. doi:10.4161/cc.7.17.6625. PMID 18728386. S2CID 14475617.
  71. ^ Willcox BJ, Donlon TA, He Q, Chen R, Grove JS, Yano K, et al. (September 2008). "FOXO3A genotype is strongly associated with human longevity". Proceedings of the National Academy of Sciences of the United States of America. 105 (37): 13987–92. Bibcode:2008PNAS..10513987W. doi:10.1073/pnas.0801030105. PMC 2544566. PMID 18765803.
  72. ^ Flachsbart F, Caliebe A, Kleindorp R, Blanché H, von Eller-Eberstein H, Nikolaus S, et al. (February 2009). "Association of FOXO3A variation with human longevity confirmed in German centenarians". Proceedings of the National Academy of Sciences of the United States of America. 106 (8): 2700–5. Bibcode:2009PNAS..106.2700F. doi:10.1073/pnas.0809594106. PMC 2650329. PMID 19196970.
  73. ^ Stefanetti RJ, Voisin S, Russell A, Lamon S (31 August 2018). "Recent advances in understanding the role of FOXO3". F1000Research. 7: 1372. doi:10.12688/f1000research.15258.1. PMC 6124385. PMID 30228872.{{cite journal}}: CS1 maint: unflagged free DOI (link)
  74. ^ Timmers PR, Wilson JF, Joshi PK, Deelen J (July 2020). "Multivariate genomic scan implicates novel loci and haem metabolism in human ageing". Nature Communications. 11 (1): 3570. Bibcode:2020NatCo..11.3570T. doi:10.1038/s41467-020-17312-3. PMC 7366647. PMID 32678081.
  75. ^ Pawlikowska L, Hu D, Huntsman S, Sung A, Chu C, Chen J, et al. (August 2009). "Association of common genetic variation in the insulin/IGF1 signaling pathway with human longevity". Aging Cell. 8 (4): 460–72. doi:10.1111/j.1474-9726.2009.00493.x. PMC 3652804. PMID 19489743.
  76. ^ Harrison DE, Strong R, Sharp ZD, Nelson JF, Astle CM, Flurkey K, et al. (July 2009). "Rapamycin fed late in life extends lifespan in genetically heterogeneous mice". Nature. 460 (7253): 392–5. Bibcode:2009Natur.460..392H. doi:10.1038/nature08221. PMC 2786175. PMID 19587680.
  77. ^ "A Special Mprize Award". Fight Aging!. 5 October 2009.
  78. ^ Kanfi, Yariv; et al. (22 February 2012). "The sirtuin SIRT6 regulates lifespan in male mice". Nature. 483 (7388): 218–21. Bibcode:2012Natur.483..218K. doi:10.1038/nature10815. PMID 22367546.
  79. ^ "The Hallmarks of Aging". Cell. 153 (6): 1194–1217. 6 June 2013. doi:10.1016/j.cell.2013.05.039. PMC 3836174. PMID 23746838. {{cite journal}}: Cite uses deprecated parameter |authors= (help)
  80. ^ Satoh, Akiko; et al. (3 September 2013). "Sirt1 Extends Life Span and Delays Aging in Mice through the Regulation of Nk2 Homeobox 1 in the DMH and LH". Cell Metabolism. 18 (3): 416–430. doi:10.1016/j.cmet.2013.07.013. PMC 3794712. PMID 24011076.
  81. ^ "Google announces Calico, a new company focused on health and well-being". News from Google. 18 September 2013.
  82. ^ Regalado, Antonio (15 December 2016). "Can naked mole rats teach us the secrets to living longer?". MIT Technology Review.
  83. ^ Naughton, John (9 April 2017). "Why Silicon Valley wants to thwart the grim reaper". The Guardian.
  84. ^ Fortuna, W. Harry (8 October 2017). "Seeking eternal life, Silicon Valley is solving for death". Quartz.
  85. ^ Mitchell, Sarah J; Martin-Montalvo, Alejandro; Mercken, Evi M; et al. (27 February 2014). "The SIRT1 Activator SRT1720 Extends Lifespan and Improves Health of Mice Fed a Standard Diet". Cell Reports. 6 (5): 836–843. doi:10.1016/j.celrep.2014.01.031. PMC 4010117. PMID 24582957.
  86. ^ Mercken, Evi M; Mitchell, Sarah J; Martin-Montalvo, Alejandro; et al. (16 June 2014). "SRT2104 extends survival of male mice on a standard diet and preserves bone and muscle mass". Aging Cell. 13 (5): 787–796. doi:10.1111/acel.12220. PMC 4172519. PMID 24931715.
  87. ^ Zhavoronkov, Alexander; Bhupinder, Bhullar (4 October 2015). "Classifying aging as a disease in the context of ICD-11". Frontiers in Genetics. 6: 326. doi:10.3389/fgene.2015.00326. PMC 4631811. PMID 26583032.{{cite journal}}: CS1 maint: unflagged free DOI (link)
  88. ^ Stambler, Ilia (1 October 2017). "Recognizing Degenerative Aging as a Treatable Medical Condition: Methodology and Policy". Aging and Disease. 8 (5): 583–589. doi:10.14336/AD.2017.0130. PMC 5614323. PMID 28966803.
  89. ^ "Opening the door to treating ageing as a disease". The Lancet Diabetes & Endocrinology. 6 (8): 587. 1 August 2018. doi:10.1016/S2213-8587(18)30214-6. PMID 30053981.
  90. ^ Calimport, Stuart; et al. (1 October 2019). "To help aging populations, classify organismal senescence". Science. 366 (6465): 576–578. Bibcode:2019Sci...366..576C. doi:10.1126/science.aay7319. PMC 7193988. PMID 31672885.
  91. ^ Khaltourina, Daria; Matveyev, Yuri; Alekseev, Aleksey; Cortese, Franco; Ioviţă, Anca (July 2020). "Aging Fits the Disease Criteria of the International Classification of Diseases". Mechanisms of Ageing and Development. 189: 111230. doi:10.1016/j.mad.2020.111230. PMID 32251691.
  92. ^ Zhang, Hongbo; Ryu, Dongryeol; Wu, Yibo; Gariani, Karim; Wang, Xu; Luan, Peiling; D'Amico, Davide; Ropelle, Eduardo R; Lutolf, Matthias P; Aebersold, Ruedi; Schoonjans, Kristina; Menzies, Keir J; Auwerx, Johan (17 June 2016). "NAD+ repletion improves mitochondrial and stem cell function and enhances life span in mice". Science. 352 (6292): 1436–1443. Bibcode:2016Sci...352.1436Z. doi:10.1126/science.aaf2693. PMID 27127236.
  93. ^ Yoshino, Jun; Mills, Kathryn F.; Yoon, Myeong Jin; Imai, Shin-ichiro (15 October 2011). "Nicotinamide mononucleotide, a key NAD+ intermediate, treats the pathophysiology of diet- and age-induced diabetes in mice". Cell Metabolism. 14 (4): 528–536. doi:10.1016/j.cmet.2011.08.014. PMC 3204926. PMID 21982712.
  94. ^ "What is NMN?". NMN.com. 5 May 2020.
  95. ^ Strong, Randy; Miller, Richard A; et al. (16 June 2016). "Longer lifespan in male mice treated with a weakly estrogenic agonist, an antioxidant, an α‐glucosidase inhibitor or a Nrf2‐inducer". Aging Cell. 15 (5): 872–884. doi:10.1111/acel.12496. PMC 5013015. PMID 27312235.
  96. ^ Boominathan, Amutha; et al. (4 September 2016). "Stable nuclear expression of ATP8 and ATP6 genes rescues a mtDNA Complex V null mutant". Nucleic Acids Research. 44 (19): 9342–9357. doi:10.1093/nar/gkw756. PMC 5100594. PMID 27596602.
  97. ^ Ben-Avraham, Danny; Govindaraju, Diddahally R.; Budagov, Temuri; Fradin, Delphine; Durda, Peter; et al. (2 June 2017). "The GH receptor exon 3 deletion is a marker of male-specific exceptional longevity associated with increased GH sensitivity and taller stature". Science Advances. 3 (6): e1602025. Bibcode:2017SciA....3E2025B. doi:10.1126/sciadv.1602025. PMC 5473676. PMID 28630896.
  98. ^ "The Nobel Prize in Physiology or Medicine 2018". NobelPrize.org.
  99. ^ "Opening the door to treating ageing as a disease". The Lancet Diabetes & Endocrinology. 6 (8): 587. 1 August 2018. doi:10.1016/S2213-8587(18)30214-6. PMID 30053981.
  100. ^ Biogerontology Research Foundation (2 July 2018). "World Health Organization adds extension code for 'aging-related' via ICD-11". EurekAlert.
  101. ^ Steve Hill (31 August 2018). "Getting Aging Classified as a Disease – Daria Khaltourina". Lifespan.io.
  102. ^ "Inching Towards the Regulatory Classification of Aging as a Disease". Fight Aging!. 3 September 2018.
  103. ^ Oksana Andreiuk (12 September 2018). "Let's talk about the World Health Organisation recognising ageing as a disease risk factor, updating the ICD for the first time in 35 years". Medium.
  104. ^ "MDI Biological Scientists Identify Pathways That Extend Lifespan by 500 Percent". MDI Biological Laboratory. 8 January 2020.
  105. ^ Michael Irving (8 January 2020). "Worm lifespans extended 500 percent in surprising new aging study". New Atlas.
  106. ^ Kristin Houser (9 January 2020). "Scientists Extend Lifespan of Worms by 500 Percent". Futurism.com.
  107. ^ Stephen Johnson (13 January 2020). "Biologists extend worm lifespan by 500% in surprising discovery on aging". Big Think.
  108. ^ "Mayo researchers demonstrate senescent cell burden is reduced in humans by senolytic drugs". Mayo Clinic. Mayo Clinic. 18 September 2019. Retrieved 20 September 2019.
  109. ^ "Senolytics decrease senescent cells in humans: Preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney disease". EBioMedicine. EBioMedicine. 20 September 2019. Retrieved 20 September 2019.
  110. ^ "Fruit flies live longer with combination drug treatment". University College London. 30 September 2019. Retrieved 2 October 2019.
  111. ^ Castillo-Quan, Jorge Iván; Tain, Luke S.; Kinghorn, Kerri J.; Li, Li; Grönke, Sebastian; Hinze, Yvonne; Blackwell, T. Keith; Bjedov, Ivana; Partridge, Linda (15 October 2019). "A triple drug combination targeting components of the nutrient-sensing network maximizes longevity". Proceedings of the National Academy of Sciences. 116 (42): 20817–20819. Retrieved 26 June 2021.
  112. ^ "In a first, scientists pinpoint neural activity's role in human longevity". Science Daily. 16 October 2019. Retrieved 28 October 2019.
  113. ^ Zullo, Joseph M.; Drake, Derek; Aron, Liviu; O’Hern, Patrick; Dhamne, Sameer C.; Davidsohn, Noah; Mao, Chai-An; Klein, William H.; Rotenberg, Alexander; Bennett, David A.; Church, George M.; Colaiácovo, Monica P.; Yankner, Bruce A. (October 2019). "Regulation of lifespan by neural excitation and REST". Nature. 574 (7778): 359–364. doi:10.1038/s41586-019-1647-8. ISSN 1476-4687. Retrieved 26 June 2021.
  114. ^ "Could cytotoxic T-cells be a key to longevity?". Science Daily. 13 November 2019. Retrieved 19 November 2019.
  115. ^ Hashimoto, Kosuke; Kouno, Tsukasa; Ikawa, Tomokatsu; Hayatsu, Norihito; Miyajima, Yurina; Yabukami, Haruka; Terooatea, Tommy; Sasaki, Takashi; Suzuki, Takahiro; Valentine, Matthew; Pascarella, Giovanni; Okazaki, Yasushi; Suzuki, Harukazu; Shin, Jay W.; Minoda, Aki; Taniuchi, Ichiro; Okano, Hideyuki; Arai, Yasumichi; Hirose, Nobuyoshi; Carninci, Piero (26 November 2019). "Single-cell transcriptomics reveals expansion of cytotoxic CD4 T cells in supercentenarians". Proceedings of the National Academy of Sciences. 116 (48): 24242–24251. Retrieved 26 June 2021.
  116. ^ "Blood iron levels could be key to slowing ageing, gene study shows". phys.org. Retrieved 18 August 2020.
  117. ^ Timmers, Paul R. H. J.; Wilson, James F.; Joshi, Peter K.; Deelen, Joris (16 July 2020). "Multivariate genomic scan implicates novel loci and haem metabolism in human ageing". Nature Communications. 11 (1): 3570. Bibcode:2020NatCo..11.3570T. doi:10.1038/s41467-020-17312-3. ISSN 2041-1723. PMC 7366647. PMID 32678081.
  118. ^ "Brain benefits of exercise can be gained with a single protein". medicalxpress.com. Retrieved 18 August 2020.
  119. ^ Horowitz, Alana M.; Fan, Xuelai; Bieri, Gregor; Smith, Lucas K.; Sanchez-Diaz, Cesar I.; Schroer, Adam B.; Gontier, Geraldine; Casaletto, Kaitlin B.; Kramer, Joel H.; Williams, Katherine E.; Villeda, Saul A. (10 July 2020). "Blood factors transfer beneficial effects of exercise on neurogenesis and cognition to the aged brain". Science. 369 (6500): 167–173. doi:10.1126/science.aaw2622. ISSN 0036-8075. Retrieved 18 August 2020.
  120. ^ "Researchers discover 2 paths of aging and new insights on promoting healthspan". phys.org. Retrieved 17 August 2020.
  121. ^ Li, Yang; Jiang, Yanfei; Paxman, Julie; O'Laughlin, Richard; Klepin, Stephen; Zhu, Yuelian; Pillus, Lorraine; Tsimring, Lev S.; Hasty, Jeff; Hao, Nan (2020). "A programmable fate decision landscape underlies single-cell aging in yeast". Science. 369 (6501): 325–329. Bibcode:2020Sci...369..325L. doi:10.1126/science.aax9552. PMC 7437498. PMID 32675375.
  122. ^ "Study reveals immune driver of brain aging". medicalxpress.com. Retrieved 13 February 2021.
  123. ^ Minhas, Paras S.; Latif-Hernandez, Amira; McReynolds, Melanie R.; Durairaj, Aarooran S.; Wang, Qian; Rubin, Amanda; Joshi, Amit U.; He, Joy Q.; Gauba, Esha; Liu, Ling; Wang, Congcong; Linde, Miles; Sugiura, Yuki; Moon, Peter K.; Majeti, Ravi; Suematsu, Makoto; Mochly-Rosen, Daria; Weissman, Irving L.; Longo, Frank M.; Rabinowitz, Joshua D.; Andreasson, Katrin I. (February 2021). "Restoring metabolism of myeloid cells reverses cognitive decline in ageing". Nature. 590 (7844): 122–128. Bibcode:2021Natur.590..122M. doi:10.1038/s41586-020-03160-0. ISSN 1476-4687. PMID 33473210. Retrieved 13 February 2021.

Literature

External links

www.longevityhistory.com — history of aging research